Raly anticorps (N-Term)
Aperçu rapide pour Raly anticorps (N-Term) (ABIN630644)
Antigène
Voir toutes Raly (RALY) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- RALY antibody was raised against the N terminal of RALY
-
Purification
- Affinity purified
-
Immunogène
- RALY antibody was raised using the N terminal of RALY corresponding to a region with amino acids NKNDPKSINSRVFIGNLNTALVKKSDVETIFSKYGRVAGCSVHKGYAFVQ
-
-
-
-
Indications d'application
-
WB: 0.5 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
RALY Blocking Peptide, (ABIN5615749), is also available for use as a blocking control in assays to test for specificity of this RALY antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RALY antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Raly (RALY) (RNA-binding protein Raly (RALY))
-
Autre désignation
- RALY
-
Sujet
- In infectious mononucleosis, anti-EBNA-1 antibodies are produced which cross-react with multiple normal human proteins. The cross-reactivity is due to anti-gly/ala antibodies that cross-react with host proteins containing configurations like those in the EBNA-1 repeat. One such antigen is RALY which is a member of the heterogeneous nuclear ribonucleoprotein gene family.
-
Poids moléculaire
- 30 kDa (MW of target protein)
Antigène
-